JP2022530890A5 - - Google Patents
Info
- Publication number
- JP2022530890A5 JP2022530890A5 JP2021564189A JP2021564189A JP2022530890A5 JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5 JP 2021564189 A JP2021564189 A JP 2021564189A JP 2021564189 A JP2021564189 A JP 2021564189A JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5
- Authority
- JP
- Japan
- Prior art keywords
- days
- body weight
- approximately
- cough
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/085180 | 2019-04-30 | ||
| CN2019085180 | 2019-04-30 | ||
| PCT/CN2020/087686 WO2020221274A1 (zh) | 2019-04-30 | 2020-04-29 | 二氨基嘧啶类化合物治疗咳嗽的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530890A JP2022530890A (ja) | 2022-07-04 |
| JP2022530890A5 true JP2022530890A5 (cg-RX-API-DMAC7.html) | 2023-05-11 |
| JP7665529B2 JP7665529B2 (ja) | 2025-04-21 |
Family
ID=73029672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564189A Active JP7665529B2 (ja) | 2019-04-30 | 2020-04-29 | ジアミノピリミジン化合物を使用することによって咳を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220211703A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3960179B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7665529B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102935436B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114007619B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020265327B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021021600A2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3067370T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021013338A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111877TA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI736243B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020221274A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1725540E (pt) * | 2004-03-05 | 2012-11-29 | Hoffmann La Roche | Diaminopirimidinas como antagonistas de p2x3 e p2x2/3 |
| ES2612890T3 (es) * | 2005-09-01 | 2017-05-19 | F. Hoffmann-La Roche Ag | Diaminopirimidinas como moduladores de P2X3 y P2X2/3 |
| DK2343281T3 (en) | 2006-10-04 | 2014-03-24 | Hoffmann La Roche | Process for the Synthesis of Phenoxydiamino-Pyrimidine Derivatives |
| PE20160431A1 (es) * | 2013-08-23 | 2016-06-02 | Afferent Pharmaceuticals Inc | Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub-aguda o cronica |
| CA2998742C (en) * | 2015-09-29 | 2023-08-29 | Anthony P. FORD | Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough |
| US10822311B2 (en) * | 2016-03-14 | 2020-11-03 | Afferent Pharmaceuticals, Inc. | Pyrimidines and variants thereof, and uses therefor |
| AU2017237929B2 (en) * | 2016-03-25 | 2021-04-15 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
-
2020
- 2020-04-29 EP EP20799419.5A patent/EP3960179B1/en active Active
- 2020-04-29 US US17/607,438 patent/US20220211703A1/en active Pending
- 2020-04-29 BR BR112021021600A patent/BR112021021600A2/pt unknown
- 2020-04-29 SG SG11202111877TA patent/SG11202111877TA/en unknown
- 2020-04-29 CN CN202080032489.4A patent/CN114007619B/zh active Active
- 2020-04-29 AU AU2020265327A patent/AU2020265327B2/en active Active
- 2020-04-29 WO PCT/CN2020/087686 patent/WO2020221274A1/zh not_active Ceased
- 2020-04-29 JP JP2021564189A patent/JP7665529B2/ja active Active
- 2020-04-29 KR KR1020217038551A patent/KR102935436B1/ko active Active
- 2020-04-29 ES ES20799419T patent/ES3067370T3/es active Active
- 2020-04-29 MX MX2021013338A patent/MX2021013338A/es unknown
- 2020-04-30 TW TW109114696A patent/TWI736243B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522486A5 (cg-RX-API-DMAC7.html) | ||
| JP2022539329A5 (cg-RX-API-DMAC7.html) | ||
| ES2617628T3 (es) | Régimen de dosificación para un agonista selectivo del receptor de S1P1 | |
| TWI717026B (zh) | 使用齊墩果酸(bardoxolone methyl)或其類似物治療和預防內皮功能障礙之方法 | |
| US10682345B2 (en) | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | |
| AU2007220047B2 (en) | Inhibition of JAK2 as a treatment of pulmonary arterial hypertension | |
| JP2013519653A5 (cg-RX-API-DMAC7.html) | ||
| JP6218940B2 (ja) | キニン系化合物、その光学異性体及びその製造方法と医薬用途 | |
| JP2009541209A5 (cg-RX-API-DMAC7.html) | ||
| JP2016526023A (ja) | Stat6阻害剤 | |
| EP2080523A1 (en) | Compositions comprising an antimuscarinic and a long-acting beta-agonist | |
| US8541433B2 (en) | Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer | |
| CN110087653A (zh) | 用于治疗肺高血压的组合疗法 | |
| JP2007500676A (ja) | 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤 | |
| JP2022531570A5 (cg-RX-API-DMAC7.html) | ||
| TW202304914A (zh) | 經取代之四環羧酸、其類似物及使用其之方法 | |
| JP2023535035A5 (cg-RX-API-DMAC7.html) | ||
| JP2007524698A5 (cg-RX-API-DMAC7.html) | ||
| JP7665529B2 (ja) | ジアミノピリミジン化合物を使用することによって咳を治療する方法 | |
| US10959992B2 (en) | Methods of treatment of asthma and COPD | |
| WO2023041024A1 (zh) | 治疗病毒感染的方法 | |
| HK40113783A (en) | Compounds and methods for treatment of viral infections | |
| CN120035442A (zh) | 治疗尘肺病的方法 | |
| WO2009104152A1 (en) | Combination treatment for ovarian cancer | |
| JP2008502639A (ja) | 咳の処置のためのキナゾリン化合物 |